TCIM
WGS icon

TOMS Capital Investment Management’s GeneDx Holdings WGS Stock Holding History

TOMS Capital Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,106
Closed -$11.7M – 50
2020
Q4 		$11.7M Buy
+32,106
New +$11.2M 0.92% 18

Other funds holding WGS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

TOMS Capital Investment Management's WGS Position: Q1 2021 in Review

TOMS Capital Investment Management sold out of GeneDx Holdings (WGS) in Q1 2021, closing a stake of 32,106 shares — an estimated $11.7M sold.

TOMS Capital Investment Management first reported a position in WGS in Q4 2020 and held it in 1 quarter. The position peaked at $11.7M in Q4 2020. 67 funds tracked by Wall St. Rank hold WGS as of Q1 2021.

  • TOMS Capital Investment Management reported no remaining GeneDx Holdings position as of Q1 2021 after selling out during the quarter.
  • TOMS Capital Investment Management sold 32,106 GeneDx Holdings shares in Q1 2021, an estimated $11.7M.
  • TOMS Capital Investment Management first reported a position in GeneDx Holdings in Q4 2020 and held it in 1 quarter.
  • TOMS Capital Investment Management's GeneDx Holdings position peaked at $11.7M in Q4 2020.
  • 67 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2021.

Based on TOMS Capital Investment Management's 13F filing for Q1 2021, filed 17 May 2021.